Allen Lin

1.8k total citations
18 papers, 957 citations indexed

About

Allen Lin is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Allen Lin has authored 18 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 9 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Allen Lin's work include Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Allen Lin is often cited by papers focused on Chronic Myeloid Leukemia Treatments (12 papers), Acute Myeloid Leukemia Research (9 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Allen Lin collaborates with scholars based in United States, Taiwan and United Kingdom. Allen Lin's co-authors include Ravi Bhatia, Su Chu, Tinisha McDonald, David S. Snyder, Yin Wei Ho, Tessa L. Holyoake, Bin Zhang, Stephen J. Forman, Sujata Chakraborty and Takahiro Maeda and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Cell.

In The Last Decade

Allen Lin

17 papers receiving 945 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allen Lin United States 9 736 393 338 188 166 18 957
Michael R. Burgess United States 16 586 0.8× 272 0.7× 370 1.1× 336 1.8× 154 0.9× 27 986
F-X Mahon France 15 496 0.7× 370 0.9× 180 0.5× 91 0.5× 230 1.4× 26 682
YinWei Ho United States 10 530 0.7× 263 0.7× 608 1.8× 262 1.4× 91 0.5× 14 1.1k
Melissa Holtz United States 9 904 1.2× 610 1.6× 318 0.9× 207 1.1× 405 2.4× 11 1.1k
Po Yee Mak United States 16 605 0.8× 270 0.7× 602 1.8× 205 1.1× 60 0.4× 57 1.1k
Linda Richmond United Kingdom 9 1.1k 1.5× 749 1.9× 317 0.9× 299 1.6× 391 2.4× 15 1.3k
Gabriele Gugliotta Italy 20 857 1.2× 704 1.8× 246 0.7× 160 0.9× 377 2.3× 60 1.1k
Matthew S. Zabriskie United States 9 416 0.6× 301 0.8× 307 0.9× 170 0.9× 113 0.7× 24 720
Takefumi Ishii United States 15 556 0.8× 523 1.3× 390 1.2× 115 0.6× 217 1.3× 20 962
Antony C. Cambareri Australia 12 505 0.7× 342 0.9× 204 0.6× 181 1.0× 233 1.4× 14 885

Countries citing papers authored by Allen Lin

Since Specialization
Citations

This map shows the geographic impact of Allen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allen Lin more than expected).

Fields of papers citing papers by Allen Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allen Lin. The network helps show where Allen Lin may publish in the future.

Co-authorship network of co-authors of Allen Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Allen Lin. A scholar is included among the top collaborators of Allen Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allen Lin. Allen Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Zhang, Bin, Su Chu, Puneet Agarwal, et al.. (2016). Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor–treated CML stem cells. Blood. 128(23). 2671–2682. 89 indexed citations
2.
Kumar, Bijender, Lei Zhang, Yunan Miao, et al.. (2015). Proteomics Profiling of Leukemia Derived Exosomes: A Potential Role in Leukemic Transformation. Blood. 126(23). 3857–3857. 2 indexed citations
3.
Zhang, Bin, Ling Li, Ching‐Cheng Chen, et al.. (2015). Knockdown (KD) of Mir-126 Expression Enhances Tyrosine Kinase Inhibitor (TKI)-Mediated Targeting of Chronic Myelogenous Leukemia (CML) Stem Cells. Blood. 126(23). 51–51. 2 indexed citations
4.
Qi, Jing, Sandeep Singh, Qi Cai, et al.. (2015). HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation. Cell stem cell. 17(5). 597–610. 85 indexed citations
5.
Aribi, Ahmed, Cédric Dos Santos, Anthony S. Stein, et al.. (2015). Combination of Dasatinib with Conventional Chemotherapy Is Associated with a High Response Rate in High Risk Acute Myeloid Leukemia (AML). Blood. 126(23). 3743–3743. 2 indexed citations
6.
Li, Liang, YinWei Ho, Allen Lin, et al.. (2014). Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells. Blood. 123(18). 2826–2837. 84 indexed citations
7.
8.
Santos, Cédric Dos, Tinisha McDonald, Yin Wei Ho, et al.. (2013). The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents. Blood. 122(11). 1900–1913. 79 indexed citations
9.
10.
Zhang, Bin, Yin Wei Ho, Qin Huang, et al.. (2012). Altered Microenvironmental Regulation of Leukemic and Normal Stem Cells in Chronic Myelogenous Leukemia. Cancer Cell. 21(4). 577–592. 271 indexed citations
11.
Pullarkat, Vinod, Liang Li, Zhuo‐Xian Meng, et al.. (2012). Deferasirox exposure induces reactive oxygen species and reduces growth and viability of myelodysplastic hematopoietic progenitors. Leukemia Research. 36(8). 966–973. 26 indexed citations
12.
Lin, Allen, Michelle Chow, Eric K. Ho, et al.. (2011). Cell recovery comparison between plasma depletion/reduction- and red cell reduction-processing of umbilical cord blood. Cytotherapy. 13(9). 1105–1119. 13 indexed citations
13.
Chu, Su, Tinisha McDonald, Allen Lin, et al.. (2011). Persistence of leukemia stem cells in chronic myelogenous leukemia patients in prolonged remission with imatinib treatment. Blood. 118(20). 5565–5572. 188 indexed citations
14.
Bhatia, Ravi, David S. Snyder, Allen Lin, et al.. (2009). A Phase I Study of the HDAC Inhibitor LBH589 in Combination with Imatinib for Patients with CML in Cytogenetic Remission with Residual Disease Detectable by Q-PCR.. Blood. 114(22). 2194–2194. 6 indexed citations
15.
Chu, Su, Allen Lin, Tinisha McDonald, et al.. (2008). Persistence of Leukemia Stem Cells in Chronic Myelogenous Leukemia Patients in Complete Cytogenetic Remission on Imatinib Treatment for 5 Years. Blood. 112(11). 194–194. 8 indexed citations
16.
Oehler, Vivian G., Ted Gooley, David S. Snyder, et al.. (2006). The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia. Blood. 109(4). 1782–1789. 95 indexed citations
17.
Lin, Allen, George A. Fisher, Sam So, Chao Tang, & Lee Levitt. (2005). A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 23(16_suppl). 4223–4223. 3 indexed citations
18.
Bhatia, Ravi, David S. Snyder, Tinisha McDonald, et al.. (2004). Feasibility and Efficacy of Mobilization of BCR/ABL- PBSC in CML Patients Receiving Imatinib.. Blood. 104(11). 2858–2858. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael R. Burgess Breakdown of academic impact, for papers by F-X Mahon Breakdown of academic impact, for papers by YinWei Ho Breakdown of academic impact, for papers by Melissa Holtz Breakdown of academic impact, for papers by Po Yee Mak Breakdown of academic impact, for papers by Linda Richmond Breakdown of academic impact, for papers by Gabriele Gugliotta Breakdown of academic impact, for papers by Matthew S. Zabriskie Breakdown of academic impact, for papers by Takefumi Ishii Breakdown of academic impact, for papers by Antony C. Cambareri
Rankless by CCL
2026